The U.S. Food and Drug Administration (FDA) has approved the first medication to treat severe frostbite, the agency announced this week. "Severe frostbite can cause white or blue skin and, later, fluid-filled blisters," said Siegel, who was not involved in the drug development. Aurlumyn is intended for severe frostbite cases, in which both the skin and the underlying tissue are frozen, and blood flow is stopped. The FDA’s approval follows a randomized clinical trial that included 47 adults with severe frostbite, who were divided into three groups. Original article source: FDA greenlights first drug for severe frostbite: ‘Very important approval’

Source: Fox News February 16, 2024 23:06 UTC